この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2020/6/221 分で読めます
Hospira, Inc., et al.; Withdrawal of Approval of 12 Abbreviated New Drug Applications; Correction
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of February 12, 2019. The document announced the withdrawal of approval of 12 abbreviated new drug applications (ANDAs) from multiple applicants. The document erroneously included ANDA 077736 for Polyethylene Glycol 3350 Powder for Oral Solution, 17 grams/scoopful, held by Breckenridge Pharmaceutical, Inc. (Breckenridge). This document corrects that error.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →